Overview of REEV

REEV is a neurotech company building the world’s first mobility care platform powered by robotics and AI to restore mobility for the 400 million people with difficulty walking.

Our flagship product, DREEVEN, is the first intelligent robotic knee orthosis empowering stroke survivors to walk 5,000 steps a day and move effortlessly between standing, sitting, and climbing stairs. In clinical studies post-stroke at Boston University, DREEVEN demonstrated a 55% increase in knee range of motion, a 31% reduction in hip compensation, and a 7.5% improvement in gait symmetry.

With $39,000 in Medicare coverage and a group of leading stroke-focused rehabilitation clinics committed to launch, REEV is unlocking an untapped $40B neuromobility market, bringing intelligent wearable robotics to millions of patients underserved by traditional orthotics.

Backed by leading venture capital firms, including brain-tech specialist Newfund, we are actively advancing our clinical roadmap in collaboration with MIT and Boston University while preparing for our next Series A in 2026.

REEV’s leadership combines award-winning innovation and world-class engineering, with CEO Amaury Ciurana, recipient of a $1M Exoskeleton Innovation Prize and HEC Mercure Award for Best Entrepreneur in North America, and CTO Robin Temporelli, a mechatronics pioneer behind automotive power-steering systems.

Our Ask

We are looking to connect with:

– Outpatient and inpatient rehabilitation clinics seeking advanced mobility solutions

– Medtech entrepreneurs with Durable Medical Equipment (DME) expertise

– Patient charities or support groups focused on stroke and mobility disorders

– Medtech investors focused on Series A or Series B

Product or Service

REEV provides an integrated mobility care solution for people living with gait disorders. The approach combines intelligent wearable robotics with clinical-grade gait analysis to deliver personalized mobility assistance and measurable outcomes.

Core Components

– DREEVEN is a lightweight robotic knee orthosis designed to support individuals with neurological gait impairments. It uses an electro-hydraulic actuator that delivers real-time knee assistance during walking. The device adapts to each user’s gait pattern and offers stability, propulsion, and controlled knee movement without restricting natural motion.

– SENSE is a gait analysis module that captures detailed biomechanical data during assessment and training. It enables clinicians to understand a patient’s mobility profile, calibrate the DREEVEN device, and track progress over time. SENSE supports evidence-based prescriptions through objective metrics.

The two systems work together to form the first AI-driven mobility care platform. SENSE configures DREEVEN for each patient, and DREEVEN collects mobility data that feeds back into the platform. This creates a continuous feedback loop for precise adjustment, clinical decision support, and long-term outcome monitoring.

Company Impact

REEV’s robotic mobility platform delivers multi-stakeholder value across the healthcare ecosystem.

– For patients, it provides AI-driven, personalized gait assistance that accelerates functional recovery and reduces fall risk in post-stroke rehabilitation.

– Caregivers benefit from reduced physical burden and remote monitoring capabilities that enable proactive, data-driven interventions.

– Payers achieve cost savings through reduced fall hospitalizations and long-term care needs, while the device remains reimbursable under HCPCS L2006.

– Hospitals gain enhanced therapist productivity and improved quality metrics, all supported by FDA-registered, HIPAA-compliant technology with seamless EMR integration.

Primary Audience

The primary beneficiaries of REEV’s solution are:

– Those affected by neurological gait disorders (Stroke, MS, SCI, etc.) who experience knee instability, reduced propulsion, and limited walking endurance.

– Clinicians and rehabilitation teams in outpatient clinics focused on neurological rehabilitation.

Partnership Opportunity